Schering CEO Hassan Will Add Personal Touch To Allergy Business Turnaround

Schering-Plough CEO Fred Hassan will be directly involved in reviving the firm's declining allergy business following the Rx-to-OTC switch of Claritin in December 2002

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet